Expertise in
28
conditions
Expertise in
28
conditions
Tristar Medical Group Children's Specialists-West Clinch Ave
2018 Clinch Ave, 
Knoxville, TN 

Overview

Jennifer Domm is a Hematologist and an Oncologist in Knoxville, Tennessee. Dr. Domm is highly rated in 28 conditions, according to our data. Her top areas of expertise are Beta Thalassemia, Niemann-Pick Disease, Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy, Bone Marrow Aspiration, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 20 peer reviewed articles and participating in 26 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology
Oncology

Licenses

Pediatrics in TN

Hospital Affiliations

Tristar Centennial Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Tristar Medical Group Children's Specialists-West Clinch Ave
2018 Clinch Ave, Knoxville, TN 37916

Additional Areas of Focus

Dr. Domm has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


26 Clinical Trials

A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
View 20 Less Clinical Trials
Similar Doctors
Expertise in
5
conditions
Hematology | Oncology
Expertise in
5
conditions
Hematology | Oncology

Tennessee Cancer Specialists PLLC

1415 Old Weisgarber Rd Ste 200, 
Knoxville, TN 
 (156.3 miles away)
Languages Spoken:
English

Russell Devore is a Hematologist and an Oncologist in Knoxville, Tennessee. Dr. Devore is highly rated in 5 conditions, according to our data. His top areas of expertise are Hypersplenism, Pleuropulmonary Blastoma, Childhood Iron Deficiency Anemia, and Lung Cancer.

Expertise in
20
conditions
Hematology | Oncology
Expertise in
20
conditions
Hematology | Oncology

Starr Regional Medical Center

1114 W Madison Ave, 
Athens, TN 
 (132.8 miles away)
Languages Spoken:
English

Stephen Miller is a Hematologist and an Oncologist in Athens, Tennessee. Dr. Miller is highly rated in 20 conditions, according to our data. His top areas of expertise are Inflammatory Breast Cancer, Non-Hodgkin Lymphoma, Paget Disease of the Breast, and Anemia.

Expertise in
12
conditions
Hematology | Oncology
Expertise in
12
conditions
Hematology | Oncology

Mark Neal Hendrixson MD

707 S Main St, 
Crossville, TN 
 (101.0 miles away)
Languages Spoken:
English
Offers Telehealth

Mark Hendrixson is a Hematologist and an Oncologist in Crossville, Tennessee. Dr. Hendrixson is highly rated in 12 conditions, according to our data. His top areas of expertise are Breast Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Familial Colorectal Cancer.

Frequently Asked Questions about Dr. Jennifer Domm

How do I make an appointment with Dr. Jennifer Domm?

You can book an appointment with Dr. Jennifer Domm by calling their office at 615-342-7339. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jennifer Domm a top-rated expert for Beta Thalassemia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jennifer Domm is classified as an Advanced expert for Beta Thalassemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jennifer Domm specialize in?

While Dr. Jennifer Domm is a Hematology, they have specific expertise in Beta Thalassemia, Niemann-Pick Disease, and Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Jennifer Domm participate in research or clinical trials?

Yes. Dr. Jennifer Domm has published 20 articles and abstracts on conditions like Beta Thalassemia. You can view a list of Dr. Jennifer Domm's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jennifer Domm accept my insurance?

Dr. Jennifer Domm accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 615-342-7339 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Domm's expertise for a condition
ConditionClose
      View All 28 Advanced Conditions
      View All 43 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile